TARA - Long Setup Possible entry above 7.32, Stop signal 5.93., First target 8.37, 2nd target momentum. Strong insider buying
−3.57USD
−40.42 MUSD
9.16 M
About Protara Therapeutics, Inc.
Sector
CEO
Jesse Shefferman
Headquarters
New York
Website
Employees (FY)
27
Founded
2006
ISIN
US74365U1079
FIGI
BBG001ZLYSH5
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.
$TARA lets go whale hunting*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Early this
Protara Therapeutics Inc 🧙Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatmen
TARA Technical Analysis 🧙Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatmen
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TARA is 2.65 USD — it has decreased by 3.80% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Protara Therapeutics, Inc. stocks are traded under the ticker TARA.
Protara Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
TARA stock is 6.48% volatile and has beta coefficient of 2.38. Check out the list of the most volatile stocks — is Protara Therapeutics, Inc. there?
One year price forecast for Protara Therapeutics, Inc. has a max estimate of 50.00 USD and a min estimate of 14.00 USD.
TARA earnings for the last quarter are −0.87 USD per share, whereas the estimation was −0.98 USD resulting in a 11.22% surprise. The estimated earnings for the next quarter are −0.92 USD per share. See more details about Protara Therapeutics, Inc. earnings.
Yes, you can track Protara Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
TARA stock has fallen by 13.83% compared to the previous week, the month change is a 34.36% fall, over the last year Protara Therapeutics, Inc. has showed a 14.39% decrease.
TARA net income for the last quarter is −10.22 M USD, while the quarter before that showed −9.86 M USD of net income which accounts for −3.66% change. Track more Protara Therapeutics, Inc. financial stats to get the full picture.
Today Protara Therapeutics, Inc. has the market capitalization of 31.44 M, it has decreased by 16.55% over the last week.
No, TARA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TARA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Protara Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 27.00 employees. See our rating of the largest employees — is Protara Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Protara Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Protara Therapeutics, Inc. stock shows the sell signal. See more of Protara Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Protara Therapeutics, Inc. future price: according to them, TARA price has a max estimate of 50.00 USD and a min estimate of 14.00 USD. Read a more detailed Protara Therapeutics, Inc. forecast: see what analysts think of Protara Therapeutics, Inc. and suggest that you do with its stocks.